AMRN has no need for a secondary ....and no financial pressure to seek a deal with anyone .
They will wait until they have the Covid data ...MITIGATE results being the final say on that .....results / settlement on the infringement case ( HealthNet might settle well before Hikma ) ...and the first year of the EU roll out ....before even considering a sale ...if even then JMO Kiwi